equipped CAR-T cells with neuraminidase (NA), an enzyme capable of removing sialic acid residues to directly target surface glycans suppressing T-cell functions and demonstrated that NA-secreting CAR-T cells had improved persistence and immunosurveillance across a wide range of tumor models. Here, XK is linked to neoplasm.